taxonomy (1)
protein (1)
source (1)
structure (0)
composition (27)
disease (1)
reference (1)
site (4)
peptide (10)
- Homo sapiens (Human)
Taxonomy
- Mammary Gland (UBERON_0001911)
Source
Reported structure
- Hex:3 HexNAc:2 (avg mass : 910.8325 )
- Hex:3 HexNAc:2 dHex:1 (avg mass : 1056.9755 )
- Hex:4 HexNAc:3 NeuAc:1 (avg mass : 1567.4278 )
- Hex:4 HexNAc:3 dHex:1 (avg mass : 1422.3129 )
- Hex:4 HexNAc:3 dHex:1 NeuAc:1 (avg mass : 1713.5708 )
- Hex:4 HexNAc:3 dHex:3 (avg mass : 1714.5989 )
- Hex:4 HexNAc:4 NeuAc:1 (avg mass : 1770.6228 )
- Hex:5 HexNAc:2 (avg mass : 1235.1173 )
- Hex:5 HexNAc:3 (avg mass : 1438.3123 )
- Hex:5 HexNAc:3 dHex:2 (avg mass : 1730.5983 )
- Hex:5 HexNAc:4 NeuAc:1 (avg mass : 1932.7652 )
- Hex:5 HexNAc:4 NeuAc:2 (avg mass : 2224.0231 )
- Hex:5 HexNAc:4 dHex:1 NeuAc:1 (avg mass : 2078.9082 )
- Hex:5 HexNAc:4 dHex:2 NeuAc:1 (avg mass : 2225.0512 )
- Hex:5 HexNAc:4 dHex:3 (avg mass : 2079.9363 )
- Hex:6 HexNAc:2 (avg mass : 1397.2597 )
- Hex:6 HexNAc:3 NeuAc:1 (avg mass : 1891.7126 )
- Hex:6 HexNAc:3 dHex:2 (avg mass : 1892.7407 )
- Hex:6 HexNAc:5 NeuAc:1 (avg mass : 2298.1026 )
- Hex:6 HexNAc:5 NeuAc:3 (avg mass : 2880.6184 )
- Hex:7 HexNAc:2 (avg mass : 1559.4021 )
- Hex:7 HexNAc:6 (avg mass : 2372.1821 )
- Hex:7 HexNAc:6 dHex:1 NeuAc:1 (avg mass : 2809.583 )
- Hex:7 HexNAc:6 dHex:5 (avg mass : 3102.8971 )
- Hex:8 HexNAc:2 (avg mass : 1721.5445 )
- Hex:9 HexNAc:2 (avg mass : 1883.6869 )
- Hex:12 HexNAc:2 (avg mass : 2370.1141 )
Composition
- Cancer, breast (DOID:1612)
Disease
- Transmembrane glycoprotein NMB / Homo sapiens
Reported glycosite
-
- Hex:3 HexNAc:2 / N-Linked (avg mass : 910.8325)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Transmembrane glycoprotein NMB / Homo sapiens
- VSVNTANVTIGPQIMEVTVYR (21aa)
- DLPIMFDVLIHDPSHFLNYSTINYK (25aa)
-
- Hex:3 HexNAc:2 dHex:1 / N-Linked (avg mass : 1056.9755)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Transmembrane glycoprotein NMB / Homo sapiens
- NDRNSSDETFIK (12aa)
- NSSDETFLK (9aa)
- DRNSSDETFLK (11aa)
- DLPIMFDVLIHDPSHFLNYSTINYK (25aa)
-
- Hex:5 HexNAc:2 / N-Linked (avg mass : 1235.1173)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Transmembrane glycoprotein NMB / Homo sapiens
- VSVNTANVTIGPQIMEVTVYR (21aa)
- VSVNTANVTLGPQLMEVTVYRR (22aa)
- DLPIMFDVLIHDPSHFLNYSTINYK (25aa)
-
- Hex:6 HexNAc:2 / N-Linked (avg mass : 1397.2597)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Transmembrane glycoprotein NMB / Homo sapiens
- VSVNTANVTIGPQIMEVTVYR (21aa)
- VSVNTANVTIGPQ (13aa)
- VSVNTANVTLGPQLMEVTVYRR (22aa)
-
- Hex:4 HexNAc:3 dHex:1 / N-Linked (avg mass : 1422.3129)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Transmembrane glycoprotein NMB / Homo sapiens
- DLPIMFDVLIHDPSHFLNYSTINYK (25aa)
-
- Hex:5 HexNAc:3 / N-Linked (avg mass : 1438.3123)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Transmembrane glycoprotein NMB / Homo sapiens
- VSVNTANVTIGPQIMEVTVYR (21aa)
-
- Hex:7 HexNAc:2 / N-Linked (avg mass : 1559.4021)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Transmembrane glycoprotein NMB / Homo sapiens
- VQAVLTSDSPALVGSNITF (19aa)
- VQAVLTSDSPALVGSNITFAVNLIFPR (27aa)
- VSVNTANVTIGPQIMEVTVYR (21aa)
-
- Hex:4 HexNAc:3 NeuAc:1 / N-Linked (avg mass : 1567.4278)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Transmembrane glycoprotein NMB / Homo sapiens
- VSVNTANVTIGPQIMEVTVYR (21aa)
- VSVNTANVTLGPQLMEVTVYRR (22aa)
- NSSDETFLK (9aa)
- DLPIMFDVLIHDPSHFLNYSTINYK (25aa)
-
- Hex:4 HexNAc:3 dHex:1 NeuAc:1 / N-Linked (avg mass : 1713.5708)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Transmembrane glycoprotein NMB / Homo sapiens
- NSSDETFLK (9aa)
- RNSSDETFLK (10aa)
- DRNSSDETFLK (11aa)
- DLPIMFDVLIHDPSHFLNYSTINYK (25aa)
-
- Hex:4 HexNAc:3 dHex:3 / N-Linked (avg mass : 1714.5989)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Transmembrane glycoprotein NMB / Homo sapiens
- NDRNSSDETFIK (12aa)
- NSSDETFLK (9aa)
-
- Hex:8 HexNAc:2 / N-Linked (avg mass : 1721.5445)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Transmembrane glycoprotein NMB / Homo sapiens
- VQAVLTSDSPALVGSNITF (19aa)
- VQAVLTSDSPALVGSNITFAVNLIFPR (27aa)
- NDRNSSDETFIK (12aa)
-
- Hex:5 HexNAc:3 dHex:2 / N-Linked (avg mass : 1730.5983)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Transmembrane glycoprotein NMB / Homo sapiens
- VSVNTANVTIGPQIMEVTVYR (21aa)
-
- Hex:4 HexNAc:4 NeuAc:1 / N-Linked (avg mass : 1770.6228)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Transmembrane glycoprotein NMB / Homo sapiens
- DLPIMFDVLIHDPSHFLNYSTINYK (25aa)
-
- Hex:9 HexNAc:2 / N-Linked (avg mass : 1883.6869)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Transmembrane glycoprotein NMB / Homo sapiens
- VSVNTANVTIGPQIMEVTVYR (21aa)
- NDRNSSDETFIK (12aa)
-
- Hex:6 HexNAc:3 NeuAc:1 / N-Linked (avg mass : 1891.7126)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Transmembrane glycoprotein NMB / Homo sapiens
- VSVNTANVTIGPQIMEVTVYR (21aa)
-
- Hex:6 HexNAc:3 dHex:2 / N-Linked (avg mass : 1892.7407)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Transmembrane glycoprotein NMB / Homo sapiens
- VSVNTANVTIGPQIMEVTVYR (21aa)
-
- Hex:5 HexNAc:4 NeuAc:1 / N-Linked (avg mass : 1932.7652)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Transmembrane glycoprotein NMB / Homo sapiens
- DLPIMFDVLIHDPSHFLNYSTINYK (25aa)
-
- Hex:5 HexNAc:4 dHex:1 NeuAc:1 / N-Linked (avg mass : 2078.9082)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Transmembrane glycoprotein NMB / Homo sapiens
- NSSDETFLK (9aa)
-
- Hex:5 HexNAc:4 dHex:3 / N-Linked (avg mass : 2079.9363)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Transmembrane glycoprotein NMB / Homo sapiens
- NSSDETFLK (9aa)
-
- Hex:5 HexNAc:4 NeuAc:2 / N-Linked (avg mass : 2224.0231)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Transmembrane glycoprotein NMB / Homo sapiens
- DLPIMFDVLIHDPSHFLNYSTINYK (25aa)
-
- Hex:5 HexNAc:4 dHex:2 NeuAc:1 / N-Linked (avg mass : 2225.0512)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Transmembrane glycoprotein NMB / Homo sapiens
- NSSDETFLK (9aa)
-
- Hex:6 HexNAc:5 NeuAc:1 / N-Linked (avg mass : 2298.1026)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Transmembrane glycoprotein NMB / Homo sapiens
- DLPIMFDVLIHDPSHFLNYSTINYK (25aa)
-
- Hex:12 HexNAc:2 / N-Linked (avg mass : 2370.1141)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Transmembrane glycoprotein NMB / Homo sapiens
- NDRNSSDETFIK (12aa)
- NSSDETFLK (9aa)
- RNSSDETFLK (10aa)
- DRNSSDETFLK (11aa)
-
- Hex:7 HexNAc:6 / N-Linked (avg mass : 2372.1821)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Transmembrane glycoprotein NMB / Homo sapiens
- RNSSDETFLK (10aa)
-
- Hex:7 HexNAc:6 dHex:1 NeuAc:1 / N-Linked (avg mass : 2809.583)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Transmembrane glycoprotein NMB / Homo sapiens
- DLPIMFDVLIHDPSHFLNYSTINYK (25aa)
-
- Hex:6 HexNAc:5 NeuAc:3 / N-Linked (avg mass : 2880.6184)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Transmembrane glycoprotein NMB / Homo sapiens
- DLPIMFDVLIHDPSHFLNYSTINYK (25aa)
-
- Hex:7 HexNAc:6 dHex:5 / N-Linked (avg mass : 3102.8971)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Transmembrane glycoprotein NMB / Homo sapiens
- NDRNSSDETFIK (12aa)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
